Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Motor neuron disease

Are diabetes and amyotrophic lateral sclerosis related?

Studies into the relationship between diabetes and amyotrophic lateral sclerosis (ALS) have produced conflicting results. In young patients, diabetes is a consistent risk factor for ALS; in older patients, diabetes protects against ALS in Europe, but increases the risk of ALS in Asia. Environment and genotype might both contribute to this variation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Multiple pathways linking diabetes and ALS.

References

  1. Dupuis, L., Pradat, P. F., Ludolph, A. C. & Loeffler, J. P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 10, 75–82 (2011).

    Article  CAS  Google Scholar 

  2. Kioumourtzoglou, M. A. et al. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol. http://dx.doi.org/10.1001/jamaneurol.2015.0910.

  3. Mariosa, D., Kamel, F., Bellocco, R., Ye, W. & Fang, F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur. J. Neurol. http://dx.doi.org/10.1111/ene.12632.

  4. Sun, Y. et al. Risk of amyotrophic lateral sclerosis in patients with diabetes: a nationwide population-based cohort study. J. Epidemiol. 25, 445–451 (2015).

    Article  Google Scholar 

  5. Turner, M. R., Goldacre, R., Ramagopalan, S., Talbot, K. & Goldacre, M. J. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81, 1222–1225 (2013).

    Article  CAS  Google Scholar 

  6. Zaldivar, T. et al. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 72, 1640–1645 (2009).

    Article  CAS  Google Scholar 

  7. Ogaki, K. et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging 33, 2527.e11–2527.e16 (2012).

    Article  CAS  Google Scholar 

  8. Palamiuc, L. et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 7, 526–546 (2015).

    Article  CAS  Google Scholar 

  9. Stallings, N. R. et al. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS ONE 8, e71793 (2013).

    Article  CAS  Google Scholar 

  10. Logroscino, G. & Ludolph, A. Amyotrophic lateral sclerosis: new ideas from cancer. Lancet Neurol. 13, 1067–1068 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giancarlo Logroscino.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Logroscino, G. Are diabetes and amyotrophic lateral sclerosis related?. Nat Rev Neurol 11, 488–490 (2015). https://doi.org/10.1038/nrneurol.2015.145

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2015.145

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing